enGene's Grant - II Round

enGene raised a round of funding on June 11, 2009. Investors include National Research Council Canada.

enGene is a Canadian biotechnology company developing an innovative mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease (IBD) and diabe…

Articles about enGene's Grant - II Round: